This work deals the application of the artificial immune system to discriminate between healthy and people with Parkinson’s disease (PWP). As the symptoms of Parkinson’s disease (PD) occur gradually and mostly targeting the elderly people for whom physical visits to the clinic are inconvenient and costly, telemonitoring of the disease using measurements of dysphonia (vocal features) has a vital...

There are many unresolved questions regarding treatment of HIV in people coinfected with HIV and HCV. There are no United States treatment guidelines created specifically for HIV/HCV coinfection. This creates confusion among coinfected people and their clinicians, and variations in patient care. The optimal sequencing of treatment for HIV and HCV is unclear. Treating HIV first may prevent HCV d...

background and aims: measles remains one of the leading causes of childhood morbidity and mortality in developing countries and is still a major public health concern in developed countries. although live attenuated vaccine is used throughout the world, out breaks of disease still occur in many countries including iran. methods: the present study was performed to evaluate the immune status agai...

introduction: studies have shown that insufficient recovery between sessions causes immune suppression. the aim of this study was to investigate the effect of repeated bouts resistance and endurance exercise on blood leukocytes, lymphocytes, neutrophils, monocytes count and plasma cortisol levels in athlete girls. materials and methods: 9 athlete girls (ages, 20-25 years), participated in the s...

We have virtually no evidence the mycobiome makes a positive contribution to human health. Fungal cell wall components such as beta-glucan bind receptors on immune cells such as phagocytes, natural killer (NK) cells, and certain classes of Tand B-lymphocytes, so one could hypothesize a beneficial effect on immunity,3 but commensal fungi are almost invariably pathogens or potential pathogens. Or...

There is a global Acquired Immune Deficiency Syndrome (AIDS) epidemic. It is estimated that the total number of people living with Human Immune deficiency Virus (HIV) is 33.2 million in the year 2007. An estimated 2.1 million people died from AIDS in 2007. As highly active antiretroviral therapy (HAART) becomes more widely used, the side effects of this regime are becoming more evident in clini...

Background: Hepatitis C (HCV) is a worldwide problem without an effective vaccine with more than 170 million chronically infected people worldwide. DNA vaccines expressing antigenic portions of the virus with adjutants have recently been developed as a novel vaccination technology. Objectives: In the present study, a DNA vaccine expressing HCV core protein was developed with IL12 as a genetic a...

Since its discovery in 1981, HIV-1 has infected almost 78 million people, and ~39 million people have died. An effective vaccine for HIV-1 remains an utmost priority. In the past several years, tremendous progress has been made in designing different immunogens and employing vaccination strategies, with the common goal of eliciting broadly neutralizing antibodies (bnAbs) and/or T cell responses...